2021年美国西班牙裔/拉丁裔人口癌症统计

IF 503.1 1区 医学 Q1 ONCOLOGY
Kimberly D. Miller MPH, Ana P. Ortiz PhD, MPH, Paulo S. Pinheiro MD, PhD, Priti Bandi PhD, Adair Minihan MPH, Hannah E. Fuchs BS, Dinorah Martinez Tyson PhD, MPH, MA, Guillermo Tortolero-Luna MD, PhD, Stacey A. Fedewa MPH, Ahmedin M. Jemal DVM, PhD, Rebecca L. Siegel MPH
{"title":"2021年美国西班牙裔/拉丁裔人口癌症统计","authors":"Kimberly D. Miller MPH,&nbsp;Ana P. Ortiz PhD, MPH,&nbsp;Paulo S. Pinheiro MD, PhD,&nbsp;Priti Bandi PhD,&nbsp;Adair Minihan MPH,&nbsp;Hannah E. Fuchs BS,&nbsp;Dinorah Martinez Tyson PhD, MPH, MA,&nbsp;Guillermo Tortolero-Luna MD, PhD,&nbsp;Stacey A. Fedewa MPH,&nbsp;Ahmedin M. Jemal DVM, PhD,&nbsp;Rebecca L. Siegel MPH","doi":"10.3322/caac.21695","DOIUrl":null,"url":null,"abstract":"<p>The Hispanic/Latino population is the second largest racial/ethnic group in the continental United States and Hawaii, accounting for 18% (60.6 million) of the total population. An additional 3 million Hispanic Americans live in Puerto Rico. Every 3 years, the American Cancer Society reports on cancer occurrence, risk factors, and screening for Hispanic individuals in the United States using the most recent population-based data. An estimated 176,600 new cancer cases and 46,500 cancer deaths will occur among Hispanic individuals in the continental United States and Hawaii in 2021. Compared to non-Hispanic Whites (NHWs), Hispanic men and women had 25%-30% lower incidence (2014-2018) and mortality (2015-2019) rates for all cancers combined and lower rates for the most common cancers, although this gap is diminishing. For example, the colorectal cancer (CRC) incidence rate ratio for Hispanic compared with NHW individuals narrowed from 0.75 (95% CI, 0.73-0.78) in 1995 to 0.91 (95% CI, 0.89-0.93) in 2018, reflecting delayed declines in CRC rates among Hispanic individuals in part because of slower uptake of screening. In contrast, Hispanic individuals have higher rates of infection-related cancers, including approximately two-fold higher incidence of liver and stomach cancer. Cervical cancer incidence is 32% higher among Hispanic women in the continental US and Hawaii and 78% higher among women in Puerto Rico compared to NHW women, yet is largely preventable through screening. Less access to care may be similarly reflected in the low prevalence of localized-stage breast cancer among Hispanic women, 59% versus 67% among NHW women. Evidence-based strategies for decreasing the cancer burden among the Hispanic population include the use of culturally appropriate lay health advisors and patient navigators and targeted, community-based intervention programs to facilitate access to screening and promote healthy behaviors. In addition, the impact of the COVID-19 pandemic on cancer trends and disparities in the Hispanic population should be closely monitored.</p>","PeriodicalId":137,"journal":{"name":"CA: A Cancer Journal for Clinicians","volume":"71 6","pages":"466-487"},"PeriodicalIF":503.1000,"publicationDate":"2021-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.3322/caac.21695","citationCount":"135","resultStr":"{\"title\":\"Cancer statistics for the US Hispanic/Latino population, 2021\",\"authors\":\"Kimberly D. Miller MPH,&nbsp;Ana P. Ortiz PhD, MPH,&nbsp;Paulo S. Pinheiro MD, PhD,&nbsp;Priti Bandi PhD,&nbsp;Adair Minihan MPH,&nbsp;Hannah E. Fuchs BS,&nbsp;Dinorah Martinez Tyson PhD, MPH, MA,&nbsp;Guillermo Tortolero-Luna MD, PhD,&nbsp;Stacey A. Fedewa MPH,&nbsp;Ahmedin M. Jemal DVM, PhD,&nbsp;Rebecca L. Siegel MPH\",\"doi\":\"10.3322/caac.21695\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The Hispanic/Latino population is the second largest racial/ethnic group in the continental United States and Hawaii, accounting for 18% (60.6 million) of the total population. An additional 3 million Hispanic Americans live in Puerto Rico. Every 3 years, the American Cancer Society reports on cancer occurrence, risk factors, and screening for Hispanic individuals in the United States using the most recent population-based data. An estimated 176,600 new cancer cases and 46,500 cancer deaths will occur among Hispanic individuals in the continental United States and Hawaii in 2021. Compared to non-Hispanic Whites (NHWs), Hispanic men and women had 25%-30% lower incidence (2014-2018) and mortality (2015-2019) rates for all cancers combined and lower rates for the most common cancers, although this gap is diminishing. For example, the colorectal cancer (CRC) incidence rate ratio for Hispanic compared with NHW individuals narrowed from 0.75 (95% CI, 0.73-0.78) in 1995 to 0.91 (95% CI, 0.89-0.93) in 2018, reflecting delayed declines in CRC rates among Hispanic individuals in part because of slower uptake of screening. In contrast, Hispanic individuals have higher rates of infection-related cancers, including approximately two-fold higher incidence of liver and stomach cancer. Cervical cancer incidence is 32% higher among Hispanic women in the continental US and Hawaii and 78% higher among women in Puerto Rico compared to NHW women, yet is largely preventable through screening. Less access to care may be similarly reflected in the low prevalence of localized-stage breast cancer among Hispanic women, 59% versus 67% among NHW women. Evidence-based strategies for decreasing the cancer burden among the Hispanic population include the use of culturally appropriate lay health advisors and patient navigators and targeted, community-based intervention programs to facilitate access to screening and promote healthy behaviors. In addition, the impact of the COVID-19 pandemic on cancer trends and disparities in the Hispanic population should be closely monitored.</p>\",\"PeriodicalId\":137,\"journal\":{\"name\":\"CA: A Cancer Journal for Clinicians\",\"volume\":\"71 6\",\"pages\":\"466-487\"},\"PeriodicalIF\":503.1000,\"publicationDate\":\"2021-09-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.3322/caac.21695\",\"citationCount\":\"135\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"CA: A Cancer Journal for Clinicians\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.3322/caac.21695\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"CA: A Cancer Journal for Clinicians","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.3322/caac.21695","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 135

摘要

西班牙裔/拉丁裔人口是美国大陆和夏威夷的第二大种族/族裔群体,占总人口的18%(6060万)。另外还有300万拉美裔美国人居住在波多黎各。每3年,美国癌症协会使用最新的基于人口的数据,报告美国西班牙裔个体的癌症发病率、风险因素和筛查情况。据估计,2021年美国大陆和夏威夷的西班牙裔人中将有176,600例新的癌症病例和46,500例癌症死亡。与非西班牙裔白人(nhw)相比,西班牙裔男性和女性所有癌症的总发病率(2014-2018年)和死亡率(2015-2019年)低25%-30%,最常见癌症的发病率更低,尽管这一差距正在缩小。例如,与非裔美国人相比,西班牙裔美国人的结直肠癌(CRC)发病率比从1995年的0.75 (95% CI, 0.73-0.78)缩小到2018年的0.91 (95% CI, 0.89-0.93),这反映了西班牙裔美国人CRC发病率下降的延迟,部分原因是筛查的接受速度较慢。相比之下,西班牙裔人患感染相关癌症的几率更高,包括肝癌和胃癌的发病率大约高出两倍。与非裔美国妇女相比,美国大陆和夏威夷的西班牙裔妇女的宫颈癌发病率高32%,波多黎各妇女的宫颈癌发病率高78%,但基本上可以通过筛查来预防。西班牙裔妇女的局部期乳腺癌患病率较低,为59%,而非西班牙裔妇女为67%,这可能同样反映了获得护理的机会较少。减少西班牙裔人口癌症负担的循证策略包括使用文化上适当的非专业健康顾问和患者导览员,以及有针对性的、基于社区的干预方案,以促进获得筛查和促进健康行为。此外,应密切监测2019冠状病毒病大流行对西班牙裔人口癌症趋势和差异的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Cancer statistics for the US Hispanic/Latino population, 2021

The Hispanic/Latino population is the second largest racial/ethnic group in the continental United States and Hawaii, accounting for 18% (60.6 million) of the total population. An additional 3 million Hispanic Americans live in Puerto Rico. Every 3 years, the American Cancer Society reports on cancer occurrence, risk factors, and screening for Hispanic individuals in the United States using the most recent population-based data. An estimated 176,600 new cancer cases and 46,500 cancer deaths will occur among Hispanic individuals in the continental United States and Hawaii in 2021. Compared to non-Hispanic Whites (NHWs), Hispanic men and women had 25%-30% lower incidence (2014-2018) and mortality (2015-2019) rates for all cancers combined and lower rates for the most common cancers, although this gap is diminishing. For example, the colorectal cancer (CRC) incidence rate ratio for Hispanic compared with NHW individuals narrowed from 0.75 (95% CI, 0.73-0.78) in 1995 to 0.91 (95% CI, 0.89-0.93) in 2018, reflecting delayed declines in CRC rates among Hispanic individuals in part because of slower uptake of screening. In contrast, Hispanic individuals have higher rates of infection-related cancers, including approximately two-fold higher incidence of liver and stomach cancer. Cervical cancer incidence is 32% higher among Hispanic women in the continental US and Hawaii and 78% higher among women in Puerto Rico compared to NHW women, yet is largely preventable through screening. Less access to care may be similarly reflected in the low prevalence of localized-stage breast cancer among Hispanic women, 59% versus 67% among NHW women. Evidence-based strategies for decreasing the cancer burden among the Hispanic population include the use of culturally appropriate lay health advisors and patient navigators and targeted, community-based intervention programs to facilitate access to screening and promote healthy behaviors. In addition, the impact of the COVID-19 pandemic on cancer trends and disparities in the Hispanic population should be closely monitored.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
873.20
自引率
0.10%
发文量
51
审稿时长
1 months
期刊介绍: CA: A Cancer Journal for Clinicians" has been published by the American Cancer Society since 1950, making it one of the oldest peer-reviewed journals in oncology. It maintains the highest impact factor among all ISI-ranked journals. The journal effectively reaches a broad and diverse audience of health professionals, offering a unique platform to disseminate information on cancer prevention, early detection, various treatment modalities, palliative care, advocacy matters, quality-of-life topics, and more. As the premier journal of the American Cancer Society, it publishes mission-driven content that significantly influences patient care.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信